Oramed Pharmaceuticals Inc.

Healthcare

NASDAQ:ORMP · NASDAQ Capital Market

Market Cap $158.59M Beta 1.24 P/E (TTM) 1.4

$3.88 +0.79%

+$0.03 today

52W Low $1.98High $5.01

Vol 0.15M · Avg 0.16M

EPS (TTM) $2.70 Div Yield 6.54%Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+94.97%

Period High

$4.73

Period Low

$1.92

Latest

$3.88

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$306.63M

MacroGenics, Inc.

NASDAQ:MGNX

$258.41M

Shattuck Labs, Inc.

NASDAQ:STTK

$232.81M

InflaRx N.V.

NASDAQ:IFRX

$130.74M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$125.30M

Kalaris Therapeutics Inc

NASDAQ:KLRS

$90.90M

Coya Therapeutics, Inc.

NASDAQ:COYA

$89.27M

ImageneBio Inc

NASDAQ:IMA

$63.61M

Clene Inc.

NASDAQ:CLNN

$60.71M

Context Therapeutics Inc.

NASDAQ:CNTX

$56.16M

What is the latest ORMP filing?

The latest filing shown is SC 13D/A dated Jun 17, 2026.

How many recent filings does ORMP have?

Intrinsic Alpha currently shows 20 recent filings for ORMP.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.